EUVIMEDEUVIMED entdecken
Crossref

Elucidating the anticancer potential of dendrobine in renal cell carcinoma treatment

Xing Jia, Zixuan Chen, Xingyu Chen, Haojie Zhang, Zongrun Sun, Zhou Wang, Min Liu

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-024-03774-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Xing Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tongren Hospital Shanghai Jiao Tong University School of Medicine, No.1111 Xian Xia Road, Shanghai, 200336, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Antineoplastic Agents, Phytogenic, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, Research Fund of Shanghai Tongren Hospital, Shanghai Jiaotong University School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsAntineoplastic Agents, PhytogenicAntineoplastic AgentsHumansCell Line, TumorCell SurvivalCell ProliferationCell MovementSTAT3 Transcription FactorApoptosisSignal TransductionDose-Response Relationship, DrugProto-Oncogene Proteins c-akt

Stichwörter der Autor:innen

DendrobineNatural productsNetwork pharmacologyPI3K/AktRenal cell carcinoma

Substanzen

STAT3 Transcription FactorSTAT3 protein, humanAntineoplastic Agents, PhytogenicAntineoplastic AgentsProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Urology, Tongren Hospital Shanghai Jiao Tong University School of Medicine, No.1111 Xian Xia Road, Shanghai, 200336, China.
  • School of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.
  • Center of Structural Heart Disease, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Department of Urology, Tongren Hospital Shanghai Jiao Tong University School of Medicine, No.1111 Xian Xia Road, Shanghai, 200336, China. Wangzhouvip1@163.com.
  • Department of Urology, Tongren Hospital Shanghai Jiao Tong University School of Medicine, No.1111 Xian Xia Road, Shanghai, 200336, China. lm4104@shtrhospital.com.

Förderung

  • the National Natural Science Foundation of China
  • Research Fund of Shanghai Tongren Hospital, Shanghai Jiaotong University School of Medicine

Zitieren

APA

Jia, X., Chen, Z., Chen, X., Zhang, H., Sun, Z., Wang, Z., & Liu, M. (2025). Elucidating the anticancer potential of dendrobine in renal cell carcinoma treatment. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03774-5

Vancouver

Jia X, Chen Z, Chen X, Zhang H, Sun Z, Wang Z, et al. Elucidating the anticancer potential of dendrobine in renal cell carcinoma treatment. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03774-5

BibTeX
@article{Jia2025,
  author = {Jia, Xing and Chen, Zixuan and Chen, Xingyu and Zhang, Haojie and Sun, Zongrun and Wang, Zhou and Liu, Min},
  title = {Elucidating the anticancer potential of dendrobine in renal cell carcinoma treatment},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-024-03774-5}
}
Kostenlos starten →